Skip header and navigation

Refine By

19 records – page 1 of 2.

Accelerated apoptosis and low bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung.

https://arctichealth.org/en/permalink/ahliterature20816
Source
Pathol Oncol Res. 1999;5(3):179-86
Publication Type
Article
Date
1999
Author
A K Eerola
H. Ruokolainen
Y. Soini
H. Raunio
P. Pääkkö
Author Affiliation
University of Oulu, Department of Pathology Kajaanintie 52 D, Oulu, FIN-90401, Finland.
Source
Pathol Oncol Res. 1999;5(3):179-86
Date
1999
Language
English
Publication Type
Article
Keywords
Adult
Aged
Apoptosis
Blotting, Western
Carcinoma, Neuroendocrine - metabolism - mortality - pathology - surgery
Carcinoma, Non-Small-Cell Lung - metabolism - mortality - pathology - surgery
Cell Differentiation
Cyclin D1 - metabolism
Female
Follow-Up Studies
Humans
Immunohistochemistry
Lung Neoplasms - metabolism - mortality - pathology - surgery
Male
Membrane Proteins - metabolism
Middle Aged
Necrosis
Neoplasm Proteins - metabolism
Prognosis
Proto-Oncogene Proteins - metabolism
Proto-Oncogene Proteins c-bcl-2 - metabolism
Survival Rate
bcl-2 Homologous Antagonist-Killer Protein
bcl-2-Associated X Protein
Abstract
In order to test the hypothesis that increased apoptotic activity is connected with neuroendocrine differentiation and low differentiation degree in large cell carcinoma (LCLC) and is regulated by bcl-2 family proteins, we analysed the extent of apoptosis and tumor necrosis and their relation to the expression of bcl-2, bax, bak and mcl-1 in 35 LCLCs, of which 20 were classified as large cell neuroendocrine lung carcinomas (LCNEC) and 15 as large cell non-neuroendocrine lung carcinomas (LCNNEC). The extent of apoptosis was determined by detecting and counting the relative and absolute numbers of apoptotic cells and bodies using in situ 3 -end labelling of the apoptotic DNA. The extent and intensity of expression of the bcl-2, bax, bak and mcl-1 proteins were studied by immunohistochemistry. Also the relative volume density of necrosis was evaluated and correlated with the other parameters. Finally, all the parameters were evaluated as prognostic markers and correlated with data on the survival of the patients. Relatively high apoptotic indices were seen in both tumor types (average for both 2.53%, range 0.09 27.01%). Significantly higher bcl-2 and bak indices were detected more often in LCNECs than in LCNNECs. Immunohistochemically detected bax, bcl-2 and bak expression was independent of apoptotic index in both tumor types, while there was a statistically significant positive association between mcl-1 expression and apoptotic index in LCNNEC but not in LCNEC. There was a statistically significant association between high apoptotic index and shortened survival in LCLC. However, no association was found between tumor stage and apoptosis. The patients with LCNEC and low bcl-2 protein expression had a significantly shorter survival time than those with high bcl-2 indices. There was also a clear association between shortened survival and necrotic LCNNEC. LCLCs show relatively high apoptotic activity, which is associated with shortened survival. The expression of bcl-2, bak and mcl- 1 is associated with neuroendocrine differentiation in LCLC. Finally, our results support some previous reports suggesting that bcl-2 expression in combination with some other markers involved in apoptosis and/or proliferation may be of prognostic value in cases of lung carcinoma with neuroendocrine differentiation.
PubMed ID
10491014 View in PubMed
Less detail

Aging influences multiple incidices of oxidative stress in the aortic media of the Fischer 344/NNiaxBrown Norway/BiNia rat.

https://arctichealth.org/en/permalink/ahliterature82960
Source
Free Radic Res. 2006 Feb;40(2):185-97
Publication Type
Article
Date
Feb-2006
Author
Rice K M
Preston D L
Walker E M
Blough E R
Author Affiliation
Marshall University, Department of Biological Sciences, Huntington, WV 2755-1090, USA.
Source
Free Radic Res. 2006 Feb;40(2):185-97
Date
Feb-2006
Language
English
Publication Type
Article
Keywords
Aging - physiology
Animals
Aorta - metabolism
Cell Proliferation
Ethidium - chemistry
Genes, src
JNK Mitogen-Activated Protein Kinases - metabolism
Ki-67 Antigen - metabolism
Mitogen-Activated Protein Kinases - metabolism
Multienzyme Complexes
NF-kappa B - genetics - metabolism
Oxidative Stress
Phenanthridines - chemistry
Phosphorylation
Protein-Serine-Threonine Kinases
Proteins - chemistry - metabolism
Proto-Oncogene Proteins c-bcl-2 - metabolism
Rats
Rats, Inbred BN
Rats, Inbred F344
TNF Receptor-Associated Factor 2 - metabolism
bcl-2-Associated X Protein - metabolism
Abstract
Here, we determine the influence of aging on multiple markers of oxidative stress in the aorta of adult (6-month), aged (30-month) and very aged (36-month) Fischer 344/NNiaHSdxBrown Norway/BiNia (F344/NxBN) rats. Compared to adults, increases in as determined by oxidation of hydroethidine (HE) to ethidium (Et) were increased 79.7+/-7.0% in 36-month aortae and this finding was highly correlated with increases in medal thickness (r=0.773, p
PubMed ID
16390828 View in PubMed
Less detail

Aging influences multiple indices of oxidative stress in the heart of the Fischer 344/NNia x Brown Norway/BiNia rat.

https://arctichealth.org/en/permalink/ahliterature83665
Source
Redox Rep. 2007;12(4):167-80
Publication Type
Article
Date
2007
Author
Asano Shinichi
Rice Kevin M
Kakarla Sunil
Katta Anjaiah
Desai Devashish H
Walker Ernest M
Wehner Paulette
Blough Eric R
Author Affiliation
Department of Biological Sciences, Marshall University, Huntington, West Virginia 25755-1090, USA.
Source
Redox Rep. 2007;12(4):167-80
Date
2007
Language
English
Publication Type
Article
Keywords
Aging - physiology
Aldehydes - metabolism
Analysis of Variance
Animals
Blood Pressure - physiology
Female
Heart - physiopathology
Heat-Shock Proteins - metabolism
Immunoblotting
Immunohistochemistry
Male
Microscopy, Fluorescence
Mitogen-Activated Protein Kinases - metabolism
Myocardium - metabolism - pathology
Oxidative Stress
Phosphorylation
Proto-Oncogene Proteins c-bcl-2 - metabolism
Rats
Rats, Inbred BN
Rats, Inbred F344
Reactive Oxygen Species - metabolism
Regression Analysis
Signal Transduction - physiology
Superoxides - metabolism
Tyrosine - analogs & derivatives - metabolism
Abstract
We report the influence of aging on multiple markers of oxidative-nitrosative stress in the heart of adult (6-month), aged (30-month) and very aged (36-month) Fischer 344/NNiaHSd x Brown Norway/BiNia (F344/NXBN) rats. Compared to adult (6-month) hearts, indices of oxidative (superoxide anion [O2*-], 4-hydroxy-2-nonenal [4-HNE]) and nitrosative (protein nitrotyrosylation) stress were 34.1 +/- 28.1%, 186 +/- 28.1% and 94 +/- 5.8% higher, respectively, in 36-month hearts and these findings were highly correlated with increases in left ventricular wall thickness (r > 0.669; r > 0.710 and P
PubMed ID
17705987 View in PubMed
Less detail

Apoptosis and expression of caspases 3, 6 and 8 in malignant non-Hodgkin's lymphomas.

https://arctichealth.org/en/permalink/ahliterature20693
Source
APMIS. 1999 Nov;107(11):1043-50
Publication Type
Article
Date
Nov-1999
Author
Y. Soini
P. Pääkkö
Author Affiliation
Department of Pathology, University of Oulu and Oulu University Hospital, Finland. msoini@cc.oulu.fi
Source
APMIS. 1999 Nov;107(11):1043-50
Date
Nov-1999
Language
English
Publication Type
Article
Keywords
Apoptosis
Caspases - metabolism
Comparative Study
Humans
Hyperplasia
Immunohistochemistry
Lymph Nodes - enzymology - metabolism - pathology
Lymphoma, High-Grade - enzymology - metabolism - pathology
Lymphoma, Low-Grade - enzymology - metabolism - pathology
Lymphoma, Non-Hodgkin - enzymology - metabolism - pathology
Proto-Oncogene Proteins - metabolism
Proto-Oncogene Proteins c-bcl-2 - metabolism
Research Support, Non-U.S. Gov't
bcl-2-Associated X Protein
Abstract
In this study we investigated the immunohistochemical expression of caspases 3, 6 and 8 in 85 malignant non-Hodgkin's lymphomas and in 4 hyperplastic lymph nodes. The extent of apoptosis and the immunohistochemical expression of bcl-2 and bax was also studied. Caspase 3 immunoreactivity was seen in 84/85 (99%), caspase 6 in 46/85 (54%), and caspase 8 in 66/85 (78%) lymphomas. The immunoreactivity for caspase 3 was diffuse cytoplasmic while antibodies to caspase 6 and 8 showed granular and fragmented, sometimes also nuclear immunopositivity. High-grade non-Hodgkin's lymphomas expressed strong caspase 6 and 8 immunoreactivity significantly more often than low-grade lymphomas (p = 0.016 and p = 0.0002, respectively). Strong caspase 3 immunoreactivity was also seen more often in high-grade lymphomas, but the association did not reach statistical significance (p = 0.14). There was a strong association between the expression of caspase 3 and 6 (p = 0.032), caspase 3 and 8 (p = 0.042), and especially between caspase 6 and 8 (p =
PubMed ID
10598877 View in PubMed
Less detail

Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity.

https://arctichealth.org/en/permalink/ahliterature22201
Source
J Pathol. 1997 Feb;181(2):172-7
Publication Type
Article
Date
Feb-1997
Author
A K Eerola
U. Törmänen
P. Rainio
R. Sormunen
R. Bloigu
K. Vähäkangas
V P Lehto
Y. Soini
P. Pääkkö
Author Affiliation
Department of Pathology, University of Oulu, Finland.
Source
J Pathol. 1997 Feb;181(2):172-7
Date
Feb-1997
Language
English
Publication Type
Article
Keywords
Apoptosis
Carcinoma, Small Cell - metabolism - pathology - surgery
Cell Division
Humans
Immunoenzyme Techniques
Lung Neoplasms - metabolism - pathology - surgery
Necrosis
Neoplasm Proteins - metabolism
Proto-Oncogene Proteins c-bcl-2 - metabolism
Research Support, Non-U.S. Gov't
Tumor Suppressor Protein p53 - metabolism
Abstract
The present study was undertaken to analyse the extent of apoptosis in operated small cell lung carcinoma (SCLC) by using in situ labelling of the oligonucleosomal DNA fragments by terminal transferase. The extent of apoptosis was compared with the cell proliferation activity, as determined by Ki-67 immunohistochemistry; with the volume density of necrosis (per cent), as determined by the morphometric point counting method; and with the occurrence of immunohistochemically detectable p53 and bcl-2 proteins. By in situ labelling, remarkably high apoptotic indices (from 0.08 to 8.10 per cent) were seen in SCLC. A high percentage of SCLSs also showed an exceptionally high proliferation activity. Aberrant accumulation of p53 protein was seen in 37.5 per cent and bel-2 overexpression in 50 per cent of SCLCs. Necrosis was seen in 82.5 per cent of SCLCs. The extent of apoptosis was inversely related to the extent of tumour necrosis (P = 0.05) and to p53 protein accumulation (P = 0.008). A positive association was found between the extent of apoptosis and bel-2 immunoreactivity (P = 0.02). The apoptotic indices (per cent) correlated with the age (P
PubMed ID
9120721 View in PubMed
Less detail

bcl-2 protein expression in cervical intraepithelial neoplasia: no evidence of a prognostic significance in mild and moderate lesions.

https://arctichealth.org/en/permalink/ahliterature20583
Source
Anticancer Res. 1999 Nov-Dec;19(6B):5463-7
Publication Type
Article
Author
A. Ciavattini
G. Lucarini
C. Castaldini
G. Goteri
C. Romanini
G. Biagini
G G Garzetti
Author Affiliation
Institute of Obstetrics and Gynecology, University of Ancona, Italy.
Source
Anticancer Res. 1999 Nov-Dec;19(6B):5463-7
Language
English
Publication Type
Article
Keywords
Adult
Cervical Intraepithelial Neoplasia - metabolism - pathology
Female
Humans
Immunohistochemistry
Prognosis
Proto-Oncogene Proteins c-bcl-2 - metabolism
Abstract
BACKGROUND: The bcl-2 proto-oncogene codes for a protein which appears to block apoptosis. In our study, we examined bcl-2 protein expression in cervical squamous metaplasia, cervical intraepithelial neoplasia (CIN) and microinvasive squamous carcinoma with the aim of identifying a relationship between bcl-2 protein expression and neoplastic development and progression. MATERIALS AND METHODS: Cervical bioptic samples were obtained from 86 white women, selected consecutively from our Colposcopic Service from January 1993 to June 1994, because of abnormal pap- smear suspicious for cervical dysplasia and/or human papilloma virus (HPV) infection. Upon histologic evaluation, 41 women had CIN, 23 cervical condyloma, and 22 squamous metaplasia. Ten patients with microinvasive squamous carcinoma, matched for age and demographic characteristics, were selected from our series of invasive cervical carcinomas and immunohistochemically analyzed. The expression of primary tumor bcl-2 protein was immunohistochemically evaluated by antihuman bcl-2 monoclonal antibody (diluted 1:100, Dako, Copenhagen, Denmark) on formalin-fixed paraffin-embedded tissue. Positive staining was expressed as a percentage of positive cells per 1000 counted dysplastic cells for each case. RESULTS: Bcl-2 immunostaining was found in all the 22 squamous metaplasias, limited to the basal layer. Nineteen of the 41 CINs (46%) were bcl-2 immunoreactive, and 2 of the 10 microinvasive carcinomas (20%). By analysing CIN lesions, the bcl-2 protein showed a striking increase in the rate of positivity with increasing severity of CIN; the bcl-2 protein expression in CINs III was significantly higher than for CINs I, CINs II or microinvasive carcinomas (P = 0.03, P = 0.02, and P = 0.03 respectively). No relationship was observed between bcl-2 immunostaining and HPV infection. bcl-2 protein expression was not useful for predicting CIN I and II evolution, although the rate of persistence/progression was higher in bcl-2 positive dysplasias (7 of 9 cases, 78%) than in negative ones (13 of 21 cases, 62%) (p = 0.88). CONCLUSIONS: Based on these results, it seems possible that the increase in bcl-2 expression in higher grade of CINs implies an increasing protection against programmed cell death, but also the induction of genetic instability in dysplastic epithelial cells and a greater capacity to evolve into invasive carcinoma.
PubMed ID
10697578 View in PubMed
Less detail

Caspases: potential targets for regulating cell death.

https://arctichealth.org/en/permalink/ahliterature17312
Source
J Cell Mol Med. 2004 Oct-Dec;8(4):432-44
Publication Type
Article
Author
A. Philchenkov
Author Affiliation
Mechanisms of Leukemogenesis Laboratory, R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, Vasilkovskaya Str. 45, 03022 Kiev, Ukraine. apoclub@mail.ru
Source
J Cell Mol Med. 2004 Oct-Dec;8(4):432-44
Language
English
Publication Type
Article
Keywords
Animals
Apoptosis
Caspases - antagonists & inhibitors - metabolism
Cytochromes c - metabolism
Enzyme Activation
Enzyme Inhibitors - chemistry - pharmacology
Gene Expression Regulation, Enzymologic
Humans
Mitochondria - metabolism
Models, Biological
Models, Chemical
Neoplasms - drug therapy
Proto-Oncogene Proteins c-bcl-2 - metabolism
Abstract
While in multicellular organisms all cells inexorably die, there are several different ways provided for the realization of cell death. One of them, apoptosis, represents a universal energy-dependent and tightly regulated physiologic process of cell death in both normal and pathologic tissues. The execution of apoptosis appears to be uniformly mediated through consecutive activation of the members of a caspase family. This review briefly summarizes current knowledge on the molecular mechanisms of caspase activation and the inhibitory components of caspase cascades. The suitability of caspases as a new potential therapeutic target is discussed next. Particular attention is focused on two broad categories of caspase-directed compounds: highly specific caspase inhibitors that distinctly block the progress of apoptosis and caspase activators that selectively induce cell death in a variety of in vitro and in vivo systems. These agents promise to be useful clinically, either alone or in combination with more conventional therapeutics.
PubMed ID
15601572 View in PubMed
Less detail

Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics.

https://arctichealth.org/en/permalink/ahliterature19608
Source
Eur J Cancer. 2001 Aug;37(12):1514-22
Publication Type
Article
Date
Aug-2001
Author
A. Ringberg
L. Anagnostaki
H. Anderson
I. Idvall
M. Fernö
Author Affiliation
Department of Plastic and Reconstructive Surgery, Malmö University Hospital, SE 205 02 Malmö, Sweden. anita.ringberg@plastsurg.mas.lu.se
Source
Eur J Cancer. 2001 Aug;37(12):1514-22
Date
Aug-2001
Language
English
Publication Type
Article
Keywords
Adult
Aged
Aged, 80 and over
Breast Neoplasms - metabolism - pathology - radiotherapy
Carcinoma, Intraductal, Noninfiltrating - metabolism - pathology - radiotherapy
DNA, Neoplasm - metabolism
Female
Flow Cytometry - methods
Follow-Up Studies
Humans
Immunohistochemistry
Ki-67 Antigen - metabolism
Middle Aged
Neoplasm Recurrence, Local - pathology
Ploidies
Proto-Oncogene Proteins c-bcl-2 - metabolism
Receptor, erbB-2 - metabolism
Receptors, Estrogen - metabolism
Receptors, Progesterone - metabolism
Research Support, Non-U.S. Gov't
Tumor Markers, Biological - metabolism
Tumor Suppressor Protein p53 - metabolism
Abstract
All cases of ductal carcinoma in situ (DCIS) diagnosed from 1987 to 1991 in the Southern Health Care Region of Sweden, and operated upon with breast conserving treatment (BCT) with (n=66) or without (n=121) postoperative radiation (RT) were clinically followed, morphologically re-evaluated and analysed for cell biological factors (immunohistochemical assays or DNA flow cytometry). Median age at diagnosis was 58 years (range 29--83 years) and median follow-up was 62 months. Oestrogen (ER)- and progesterone receptor (PR)-negativity, c-erbB-2 overexpression, low bcl-2 expression, p53 accumulation, DNA non-diploidy and high Ki67, were strongly associated with high grade DCIS, and comedo-type necrosis. In contrast, significant associations to growth pattern (not diffuse versus diffuse) were seen only for c-erbB-2 and PgR. There was also a strong relationship between the cell biological factors, and a summary cell biological index based on principal component analysis was introduced (CBI-7). In the group that had not received postoperative RT, 31 ipsilateral local recurrences occurred (13 invasive, 18 DCIS). Ipsilateral recurrence-free interval (IL-RFI) was in univariate analyses significantly, or almost significantly, shorter for patients showing p53 accumulation, high Ki67 or low bcl-2, compared with patients with normal p53, low Ki67 and high bcl-2. The prognostic importance of the remaining cell biological factors was less pronounced. On the other hand, the index CBI-7, was a strong predictor for recurrence.
PubMed ID
11506959 View in PubMed
Less detail

Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.

https://arctichealth.org/en/permalink/ahliterature20737
Source
J Clin Oncol. 1999 Jul;17(7):2061
Publication Type
Article
Date
Jul-1999
Author
M. Baekelandt
G B Kristensen
J M Nesland
C G Tropé
R. Holm
Author Affiliation
Departments of Gynecologic Oncology and Pathology, The Norwegian Radium Hospital, Montebello, Oslo, Norway.
Source
J Clin Oncol. 1999 Jul;17(7):2061
Date
Jul-1999
Language
English
Publication Type
Article
Keywords
Adult
Aged
Analysis of Variance
Apoptosis
Disease-Free Survival
Female
Follow-Up Studies
Humans
Immunohistochemistry
Middle Aged
Norway - epidemiology
Nuclear Proteins
Ovarian Neoplasms - metabolism - mortality - pathology
Predictive value of tests
Prognosis
Proportional Hazards Models
Proto-Oncogene Proteins - metabolism
Proto-Oncogene Proteins c-bcl-2 - metabolism
Proto-Oncogene Proteins c-mdm2
Research Support, Non-U.S. Gov't
Survival Rate
Tumor Markers, Biological - metabolism
Tumor Suppressor Protein p53 - metabolism
Abstract
PURPOSE: To investigate the prognostic and predictive relevance of p53, Mdm2, and Bcl-2 protein expression in advanced ovarian cancer. PATIENTS AND METHODS: Tumor biopsy specimens from 185 consecutive and homogeneously treated patients with stage III ovarian cancer were examined immunohistochemically for expression of p53, Mdm2, and Bcl-2 proteins. Both uni- and multivariate analyses of prognostic factors were performed, and correlations with classical clinicopathologic parameters and response to chemotherapy were examined. RESULTS: Forty-nine percent and 39% of cases were considered positive for expression of p53 and Bcl-2, respectively. p53 expression was correlated with loss of histologic differentiation and Bcl-2 expression with smaller residual disease after primary surgery. The absence of p53 expression and the presence of Bcl-2 expression were associated with improved survival but not with overall response to chemotherapy, although a positive correlation was found between Bcl-2 expression and the possibility of obtaining a completely negative second-look laparotomy. Expression of Mdm2 was found in 17% of cases. Although correlations were found with known favorable clinicopathologic factors, no prognostic significance was demonstrated for Mdm2 in this patient group. In multivariate analyses, histologic type, degree of differentiation, residual disease, and p53 alone or combined with Bcl-2 expression were found to be independently associated with overall survival. CONCLUSION: p53, and especially the combination of p53 and Bcl-2 expression data, represents an independent prognostic predictor in stage III ovarian cancer. Despite their role in the apoptotic process, p53 and Bcl-2 do not seem to be clinically useful predictors of response to combination chemotherapy in these patients.
PubMed ID
10561259 View in PubMed
Less detail

Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system.

https://arctichealth.org/en/permalink/ahliterature140014
Source
Acta Obstet Gynecol Scand. 2010 Nov;89(11):1438-46
Publication Type
Article
Date
Nov-2010
Author
Anne Orbo
Marit Arnes
Inger Pettersen
Kurt Larsen
Karin Hanssen
Bjorn Moe
Author Affiliation
Institute of Medical Biology, University of Tromsø, Norway. anne.orbo@uit.no
Source
Acta Obstet Gynecol Scand. 2010 Nov;89(11):1438-46
Date
Nov-2010
Language
English
Publication Type
Article
Keywords
Adult
Caspase 2 - metabolism
Contraceptives, Oral, Synthetic - administration & dosage
Down-Regulation
Endometrial Hyperplasia - drug therapy - genetics - metabolism - pathology
Estrogen Receptor alpha - metabolism
Estrogen Receptor beta - metabolism
Female
Humans
Immunohistochemistry
Intrauterine Devices, Medicated
Levonorgestrel - administration & dosage
Metallothionein - metabolism
Middle Aged
Norway
Proto-Oncogene Proteins c-bcl-2 - metabolism
Receptors, Progesterone - genetics - metabolism
Retrospective Studies
Statistics, nonparametric
bcl-2-Associated X Protein - metabolism
Abstract
To investigate whether regression of endometrial hyperplasia observed after 3 months of treatment with levonorgestrel impregnated intrauterine system device (LNG-IUS) was sustained after 6 months and whether these effects were still occurring synchronously with extinguished expression of progesterone receptors and increased apoptosis.
Retrospective population-based observational study.
Six local hospitals and one university hospital in northern Norway.
Patients (n = 41) with low and medium risk endometrial hyperplasia.
Histopathological treatment response comparing LNG-IUS (n = 25) and standard per oral medroxyprogesterone (n = 16). Expression of progesterone receptor A (PR-A), progesterone receptor B (PR-B), ER-alpha, ER-beta, Bcl-2, BAX, Caspase-3 and metallothionein (MT) were investigated by immunohistochemistry; results were evaluated by a semi-quantitative H-score.
Response to progestin treatment.
All the LNG-IUS treated patients had therapy response after 6 months. PR-A and PR-B in glands were almost extinguished for IUD users compared to the oral group. Estrogen receptors were also reduced. Co-existent changes in apoptosis were differently modulated in glands and stroma in the two treatment groups. Bcl-2 was different in glands and stroma in responders and non-responders to oral therapy.
The study confirms that LNG-IUS can be safely used for 6 months as treatment for endometrial hyperplasia. The clinical effect is accompanied by almost extinguished PR-receptors in glands coinciding with modulation of apoptosis. The results strongly indicate that progestins activate non-classical initiated signaling pathways.
PubMed ID
20955098 View in PubMed
Less detail

19 records – page 1 of 2.